Protagenic Therapeutics Inc PTIXW:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/07/21 EDT
0.50quote price arrow up+0.18 (+56.16%)
Volume
12,010
Close
0.32UNCH (UNCH)
Volume
18,825
52 week range
0.28 - 0.42

...

Loading . . .
  • Open0.34
  • Day High0.34
  • Day Low0.32
  • Prev Close0.32
  • 52 Week High0.42
  • 52 Week High Date04/27/21
  • 52 Week Low0.28
  • 52 Week Low Date04/28/21

Key Stats

  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume0.08M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open0.34
  • Day High0.34
  • Day Low0.32
  • Prev Close0.32
  • 52 Week High0.42
  • 52 Week High Date04/27/21
  • 52 Week Low0.28
  • 52 Week Low Date04/28/21
  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume0.08M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Protagenic Therapeutics Inc

There is no recent news for this security.

Profile

MORE
Protagenic Therapeutics, Inc., formerly Atrinsic, Inc., is a development-stage company. The Company is a biotechnology company that specializes in the discovery and development of therapeutics to treat central nervous system (CNS) disorders. The Company provides treatments for mood, anxiety, depression and neurodegenerative disorders by using peptide-base, brain active therapeutics. The Company has developed a portfolio of neuropeptides that are in various stages of...
Garo Armen Ph.D.
Chairman
Alexander Arrow M.D.
Chief Financial Officer
Address
149 5th Ave Rm 500
New York, NY
10010-6826
United States